Alemtuzumab Is Safe and Associated With High Response Rates In Selected Patients With Myelodysplastic Syndrome
暂无分享，去创建一个
N. Young | C. Hourigan | P. Scheinberg | A. Barrett | M. Olnes | A. Parikh | Colin O. Wu | B. Weinstein | A. Shenoy | R. Desmond